These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22927670)

  • 1. Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients.
    Mitchell AJ; Vancampfort D; De Herdt A; Yu W; De Hert M
    Schizophr Bull; 2013 Mar; 39(2):295-305. PubMed ID: 22927670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.
    Mitchell AJ; Vancampfort D; Sweers K; van Winkel R; Yu W; De Hert M
    Schizophr Bull; 2013 Mar; 39(2):306-18. PubMed ID: 22207632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.
    Fleischhacker WW; Siu CO; Bodén R; Pappadopulos E; Karayal ON; Kahn RS;
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):987-95. PubMed ID: 23253821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking Affects the Patterns of Metabolic Disorders and Metabolic Syndrome in Patients With First-Episode Drug-Naive Schizophrenia: A Large Sample Study Based on the Chinese Han Population.
    Li Z; Wang S; Chen Y; Wu X; Gu Y; Lang X; Wu F; Zhang XY
    Int J Neuropsychopharmacol; 2021 Oct; 24(10):798-807. PubMed ID: 34153098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care.
    Seow LS; Chong SA; Wang P; Shafie S; Ong HL; Subramaniam M
    Compr Psychiatry; 2017 Apr; 74():196-203. PubMed ID: 28214752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of metabolic syndrome and its components among overweight and obese Nigerian adolescents and young adults.
    Onyenekwu CP; Dada AO; Babatunde OT
    Niger J Clin Pract; 2017 Jun; 20(6):670-676. PubMed ID: 28656920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome and diabetes mellitus as predictors of thoracic aortic calcification as detected by non-contrast computed tomography in the Multi-Ethnic Study of Atherosclerosis.
    Katz R; Budoff MJ; O'Brien KD; Wong ND; Nasir K
    Diabet Med; 2016 Jul; 33(7):912-9. PubMed ID: 26341116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia.
    Lang X; Liu Q; Fang H; Zhou Y; Forster MT; Li Z; Zhang X
    Psychopharmacology (Berl); 2021 Dec; 238(12):3643-3652. PubMed ID: 34586464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review.
    Wysokiński A; Kowman M; Kłoszewska I
    Psychiatr Danub; 2012 Sep; 24(3):314-22. PubMed ID: 23013638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia: A Systematic Review and Meta-analysis.
    Hagi K; Nosaka T; Dickinson D; Lindenmayer JP; Lee J; Friedman J; Boyer L; Han M; Abdul-Rashid NA; Correll CU
    JAMA Psychiatry; 2021 May; 78(5):510-518. PubMed ID: 33656533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
    Pallava A; Chadda RK; Sood M; Lakshmy R
    Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
    Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
    Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo.
    L'Italien GJ; Casey DE; Kan HJ; Carson WH; Marcus RN
    J Clin Psychiatry; 2007 Oct; 68(10):1510-6. PubMed ID: 17960964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial.
    Storch Jakobsen A; Speyer H; Nørgaard HCB; Hjorthøj C; Krogh J; Mors O; Nordentoft M
    Schizophr Res; 2018 Sep; 199():96-102. PubMed ID: 29501386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population?
    Castillo-Sánchez M; Fàbregas-Escurriola M; Bergè-Baquero D; Fernández-SanMartín M; Goday-Arno A
    Clin Exp Hypertens; 2017; 39(5):441-447. PubMed ID: 28590147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure control and components of the metabolic syndrome: the GOOD survey.
    Zidek W; Naditch-Brûlé L; Perlini S; Farsang C; Kjeldsen SE
    Cardiovasc Diabetol; 2009 Sep; 8():51. PubMed ID: 19754934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiometabolic risk in first-episode schizophrenia (FES) patients with the earliest stages of both illness and antipsychotic treatment.
    Zhai D; Cui T; Xu Y; Feng Y; Wang X; Yang Y; Li S; Zhou D; Dong G; Zhao Y; Yang Y; Zhang R
    Schizophr Res; 2017 Jan; 179():41-49. PubMed ID: 27613506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence Of Metabolic Syndrome Among Apparently Healthy Workforce.
    Roomi MA; Mohammadnezhad M
    J Ayub Med Coll Abbottabad; 2019; 31(2):252-254. PubMed ID: 31094127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia.
    Quek YF; See YM; Yee JY; Rekhi G; Ng BT; Tang C; Lee J
    Asian J Psychiatr; 2022 Aug; 74():103192. PubMed ID: 35751958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.